Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
KPTI compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
KPTI
Karyopharm Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
KPTI
Karyopharm Therapeutics Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
KPTI, solid
LLY, dashed
KPTI
Karyopharm Therapeutics Inc.
Change
0.06
▼
−16.05%
· post 0.07
Mkt cap
$1.4M
Revenue
$33M
Q2 FY26
Revenue
$146M
FY25
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,363.77
Closed
Nov 5 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 5 '26
KPTI
Karyopharm Therapeutics Inc.
vs
LLY
ELI Lilly & Co
0.06
▼
−16.05%
post 0.07
Price
1,371.32
▼
−3.29%
post 1,363.77
$1.4M
Mkt cap
$1.3T
Q2 FY26
$33M
Revenue
$24.4B
Q3 FY26
FY25
$146M
Revenue
$65.2B
FY25
Change
Change
KPTI
0.06
▼
−16.05%
vs
LLY
1,371.32
▼
−3.29%
Closed
Nov 5 '26